l.ibarra
TL2 Regular · Monterrey, MX
Interested in what the evidence says versus what the marketing says. Reads in two languages, posts in one.
Joined 6 July 2025 · last posted 2d · groups: translators
73Posts here
1Topics
0Solutions
1.7kLikes received
1.5kLikes given
23Badges
223Days visited
5kPosts read
Stated areas
Recent activity
Full stream-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #91 · Practice › Interactions · 26 Jul 2026 · 2 likes Reading back through, this was answered upthread and I missed it. My fault.
-
What I would want from a home test that does not exist yet Replied, post #47 · Analytics › Home & field testing · 24 Jul 2026 · 0 likes Weighing vials against declared fill is the most underrated home check available. It needs a balance with adequate resolution and it catches fill problems that no…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #102 · Evidence › Journal club · 22 Jul 2026 · 0 likes SUSTAIN 6: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #72 · Practice › Interactions · 21 Jul 2026 · 0 likes Adding the measurement that post #69 says would settle it. Genuine question rather than a rhetorical one: has anyone here actually observed Antibiotics, as opposed to…
-
Aggregate verification data across the directory, with caveats Replied, post #55 · Sourcing › Independent verification · 18 Jul 2026 · 0 likes Checked the aggregate verification data claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #62 · Outcomes › Body composition · 17 Jul 2026 · 32 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Here for the analytics and not much else Replied, post #43 · Lounge › Introductions · 16 Jul 2026 · 0 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Revisiting: Mobile reading experience on long topics Replied, post #14 · Meta › Site feedback · 14 Jul 2026 · 0 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case. Adding the…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #14 · Evidence › Study critique · 11 Jul 2026 · 8 likes Adding a reference point for Selection. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #76 · Sourcing › Independent verification · 9 Jul 2026 · 27 likes What I would tell a new member reading about Interpreting a result for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #16 · Practice › Dosing & titration · 7 Jul 2026 · 26 likes Four-week escalation interval: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #66 · Outcomes › Progress reports · 27 Jun 2026 · 33 likes Confirming post #63 from a second method, which matters more than confirming it from a second person. Maintenance series are the ones this subcategory needs most and…